Key Financial Data Of Reporting Company

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7548751

Concept 2023-01-01 to
2023-06-30
As at
2023-06-30
2023-04-01 to
2023-06-30
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-06-30
2022-04-01 to
2022-06-30
As at
2022-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
73,625,000,000 JPY
166,258,000,000 JPY
71,264,000,000 JPY
Ordinary profit (loss)
11,174,000,000 JPY
28,281,000,000 JPY
10,904,000,000 JPY
Net assets
208,591,000,000 JPY
197,900,000,000 JPY
199,413,000,000 JPY
Total assets
266,573,000,000 JPY
255,827,000,000 JPY
250,823,000,000 JPY
Basic earnings (loss) per share
103.35
55.92
259.63
99.55
54.70
Diluted earnings per share
259.59
Equity-to-asset ratio
0.781 xbrli:pure
0.773 xbrli:pure
0.794 xbrli:pure
Net cash provided by (used in) operating activities
7,246,000,000 JPY
31,914,000,000 JPY
18,819,000,000 JPY
Net cash provided by (used in) investing activities
-8,083,000,000 JPY
-14,312,000,000 JPY
-781,000,000 JPY
Net cash provided by (used in) financing activities
-4,061,000,000 JPY
-20,759,000,000 JPY
-7,724,000,000 JPY
Cash and cash equivalents
75,586,000,000 JPY
79,480,000,000 JPY
93,584,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.